Evidence map›Paper›PMID 33918516›Full record

Trial reportInternational journal of molecular sciences2021

The Effect of Far-Infrared Therapy on the Peritoneal Expression of Glucose Degradation Products in Diabetic Patients on Peritoneal Dialysis.

Chia-Ning Chang, Chih-Yuan Niu, Ann Charis Tan, Chia-Hao Chan, Chun-Fan Chen, Tz-Heng Chen, Szu-Yuan Li, Yung-Tai Chen, Fan-Yu Chen, Wen-Sheng Liu and 2 more

Open access · goldAbstract readClinical Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Chia-Ning ChangInstitute of Food Safety and Health Risk Assessment, National Yang Ming Chiao Tung University, Hsinchu 300, Taiwan.ORCID 0000-0002-7293-9004
Chih-Yuan NiuSchool of Medicine, National Yang Ming Chiao Tung University, Hsinchu 300, Taiwan.
Ann Charis TanDepartment of Medicine, Division of Nephrology, Taipei Veterans General Hospital, Taipei 112, Taiwan.
Chia-Hao ChanDepartment of Medicine, Division of Nephrology, Taipei Veterans General Hospital, Taipei 112, Taiwan.
Chun-Fan ChenSchool of Medicine, National Yang Ming Chiao Tung University, Hsinchu 300, Taiwan.ORCID 0000-0003-1932-3590
Tz-Heng ChenSchool of Medicine, National Yang Ming Chiao Tung University, Hsinchu 300, Taiwan.ORCID 0000-0003-4101-8824
Szu-Yuan LiSchool of Medicine, National Yang Ming Chiao Tung University, Hsinchu 300, Taiwan.
Yung-Tai ChenSchool of Medicine, National Yang Ming Chiao Tung University, Hsinchu 300, Taiwan.
Fan-Yu ChenSchool of Medicine, National Yang Ming Chiao Tung University, Hsinchu 300, Taiwan.
Wen-Sheng LiuInstitute of Food Safety and Health Risk Assessment, National Yang Ming Chiao Tung University, Hsinchu 300, Taiwan.
Chih-Ching LinSchool of Medicine, National Yang Ming Chiao Tung University, Hsinchu 300, Taiwan.
Guor-Jien WeiInstitute of Food Safety and Health Risk Assessment, National Yang Ming Chiao Tung University, Hsinchu 300, Taiwan.
National Yang Ming Chiao Tung University · TWTaipei Veterans General Hospital · TW

Funding

Taipei, Taichung, Kaohsiung Veterans General Hospital, Tri-Service General Hospital, Academia Sinica Joint Research Program VTA108-V1-2-2Taipei, Taichung, Kaohsiung Veterans General Hospital, Tri-Service General Hospital, Academia Sinica Joint Research Program VTA109-V1-2-1Taipei Veterans General Hospital V108C-053Taipei Veterans General Hospital V109C-171Taipei Veterans General Hospital V110C-073
6 · The paper itself

Abstract

Peritoneal dialysis (PD) is a treatment modality for end-stage renal disease (ESRD) patients. Dextrose is a common osmotic agent used in PD solutions and its absorption may exacerbate diabetes mellitus, a common complication of ESRD. PD solutions also contain glucose degradation products (GDPs) that may lead to encapsulating peritoneal sclerosis (EPS), a severe complication of PD. A previous study showed that far-infrared (FIR) therapy improved a patient's gastrointestinal symptoms due to EPS. Due to limited literature on the matter, this study aims to investigate dialysate GDPs and peritoneal function in diabetic patients on PD. Thirty-one PD patients were enrolled and underwent 40 min of FIR therapy twice daily for six months. We demonstrated the effect of FIR therapy on the following: (1) decrease of methylglyoxal

Indexed as

Peritoneal DialysisAdultAgedDiabetes ComplicationsDialysis SolutionsFemaleGlucoseHumansInfrared RaysKidney Failure, ChronicMaleMiddle AgedDialysis SolutionsGlucosediabetes mellitusfar-infrared therapyglucose degradation productsperitoneal dialysis

Identifiers

PMID33918516
PMCPMC8038268
OpenAlexW3146982394

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.